CellCarta
  • Newsletter
  • Careers
  • News
  • Contact
LinkedIn Twitter facebook
Recherche
fr
  • Solutions
    Services
    • Antigen Presentation
      • NEOEPITOPE DIRECT™
    • Bioanalytical Solutions
      • Clinical Biomarkers
      • PK Assays
      • Receptor Occupancy Assays
    • Bioinformatics and Datamining
      • Bioinformatics and Biostatistics
      • Antigen AtlasTM Database
      • CellEngineTM Software
    • Biologics Characterization – CMC
      • HCP Analysis
    • Biomarkers Development and Validation Services
    • Cell-Based Immune Profiling
      • Basophil Activation Test (BAT)
      • Cell Enumeration
      • Cellular Phenotyping
      • Cellular Proliferation and Cell Cycling
      • Fluorescence-Activated Cell Sorting (FACS)
      • Intracellular Cytokine Staining (ICS)
      • MDSC Assays
      • Pathway Mapping
      • Receptor Occupancy (RO) Assays
      • Surface Profiling
    • Clinical Lab Services
      • Clinical Laboratory Services
      • Quality Management Systems
    • Clinical Proteomics
      • B-cell Maturation Antigen (BCMA)
      • Clinically Relevant Biomarkers in FFPE
    • COVID-19 Clinical Testing for Drug Development
    • Diagnostic Tests (Belgium)
    • Genomics
      • All Genomic Services
      • Antisense Oligonucleotide (ASO) Drug Development
      • Digital PCR (dPCR)
      • Quantitative PCR
    • Histopathology
      • All Histopathology Services
      • IHC-IF
      • ISH
      • MOSAIC Laboratories – A CellCarta Company
      • Pathology Team
      • Digital Pathology and Image Analysis
    • Immunoassays
    • Immunogenicity Assessment
    • Mass Spectrometry-based Biomarker Services
    • Support Services for Clinical Studies
      • Clinical Site Training
      • Sample Management & Logistics
      • Sample Procurement
    Technologies
    • ELISA
    • ELISpot and FluoroSpot
    • Olink® PEA Technology
    • Mass Cytometry (CyTOF)
    • Mass Spectrometry
    • MSD®
    • Multiparametric Flow Cytometry
    • NanostringTM
    Therapeutic Areas
    • Oncology
    • Infectious Diseases
    • Immunology
    • Neurosciences
    Phases
    • Discovery Phase
    • Preclinical Phase
    • Clinical Phase
    • Biologic Manufacturing
  • Science Hub
    • Brochures
    • Case Studies
    • CellTalk
    • Infographics
    • Insight from our experts
    • Posters
    • Press Releases
    • Scientific Publications
    • Videos
    • Web News
    • Webinars
    • White Papers
  • Events
  • About us
Services
  • Antigen Presentation
    • NEOEPITOPE DIRECT™
  • Bioanalytical Solutions
    • Clinical Biomarkers
    • PK Assays
    • Receptor Occupancy Assays
  • Bioinformatics and Datamining
    • Bioinformatics and Biostatistics
    • Antigen AtlasTM Database
    • CellEngineTM Software
  • Biologics Characterization – CMC
    • HCP Analysis
  • Biomarkers Development and Validation Services
  • Cell-Based Immune Profiling
    • Basophil Activation Test (BAT)
    • Cell Enumeration
    • Cellular Phenotyping
    • Cellular Proliferation and Cell Cycling
    • Fluorescence-Activated Cell Sorting (FACS)
    • Intracellular Cytokine Staining (ICS)
    • MDSC Assays
    • Pathway Mapping
    • Receptor Occupancy (RO) Assays
    • Surface Profiling
  • Clinical Lab Services
    • Clinical Laboratory Services
    • Quality Management Systems
  • Clinical Proteomics
    • B-cell Maturation Antigen (BCMA)
    • Clinically Relevant Biomarkers in FFPE
  • COVID-19 Clinical Testing for Drug Development
  • Diagnostic Tests (Belgium)
  • Genomics
    • All Genomic Services
    • Antisense Oligonucleotide (ASO) Drug Development
    • Digital PCR (dPCR)
    • Quantitative PCR
  • Histopathology
    • All Histopathology Services
    • IHC-IF
    • ISH
    • MOSAIC Laboratories – A CellCarta Company
    • Pathology Team
    • Digital Pathology and Image Analysis
  • Immunoassays
  • Immunogenicity Assessment
  • Mass Spectrometry-based Biomarker Services
  • Support Services for Clinical Studies
    • Clinical Site Training
    • Sample Management & Logistics
    • Sample Procurement
Technologies
  • ELISA
  • ELISpot and FluoroSpot
  • Olink® PEA Technology
  • Mass Cytometry (CyTOF)
  • Mass Spectrometry
  • MSD®
  • Multiparametric Flow Cytometry
  • NanostringTM
Therapeutic Areas
  • Oncology
  • Infectious Diseases
  • Immunology
  • Neurosciences
Phases
  • Discovery Phase
  • Preclinical Phase
  • Clinical Phase
  • Biologic Manufacturing
Close icon
Close icon

Case Study: mMDSC Assay

Home > Science Hub > Case Study: mMDSC Assay
Back to the list Next article Previous article

October 19, 2020

DOWNLOAD OUR CASE STUDY

CaseStudy_MDSC

ACCURATELY MONITOR mMDSC AND THEIR IMPACT ON IMMUNOTHERAPIES

Contact us to get your project started

MDSC Assays Contact
Email
LinkedIn
Twitter
Facebook

You might also be interested by

Web News

CellCarta Providing Advanced Cytometry Analysis Software CellEngine to Teiko Bio

March 10, 2022

Flow Cytometry

More info

Webinars

Fast, Metadata-Driven Analysis and Visualization of Flow and Mass Cytometry Data with CellEngine

February 4, 2022

Flow Cytometry

More info

Posters

Monitoring MDSC – A Hurdle to Immune Checkpoints Inhibitors

November 9, 2020

Flow Cytometry

More info

Posters

Multiple Myeloma Flow Cytometry Panel Validated for Clinical Monitoring of Patients

November 9, 2020

Flow Cytometry

More info
CellCarta

201 President Kennedy Ave.
Suite 3900
Montreal, Quebec
Canada H2X 3Y7
+1 514.360.3600 | +1 877.776.3443
info@cellcarta.com

CellCarta has a global presence for expertise where you need it.

Contact us

Subscribe to our newsletter

Newsletter

Follow us

LinkedIn
Twitter facebook

© 2022 CellCarta - All rights reserved.

Privacy policy Manage cookies